{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Antithrombotic Regimens in Peripheral Arterial Disease"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants included individuals with PAD, defined by symptoms, previous procedures, or objective evidence of malperfusion."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention involved various antithrombotic regimens compared to placebo or other regimens."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to evaluate the efficacy and risks of antithrombotic regimens in preventing major cardiovascular events, vascular limb events, and mortality in PAD patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was a composite of major adverse cardiovascular events (MACE) and major adverse limb events (MALE) over the longest reported follow-up."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not specified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding details were not provided."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Data were extracted and analysed using intention-to-treat principles."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The primary outcome showed a significant reduction in MACE and MALE with certain antithrombotic regimens."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events, including major bleeding, were reported, with varying frequencies across regimens."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The study was registered with PROSPERO (CRD42023389262)."
      },
      "Funding": {
        "score": 0,
        "evidence": "The study's funding source was not specified."
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}